| Patents for C07D 211 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings (37,939) |
|---|
| 05/22/2003 | WO2003042178A1 Novel piperidine derivatives as modulators of chemokine receptors |
| 05/22/2003 | WO2003042177A1 Piperidine derivatives and their use as modulators of chemokine receptor activity (especially ccr5) |
| 05/22/2003 | WO2003042174A1 Cannabinoid receptor ligands |
| 05/22/2003 | WO2003042173A1 Nk1 antagonists |
| 05/22/2003 | WO2003041707A1 N-adamantylmethyl derivates and intermediates as pharmaceutical compositions and processes for their preparation |
| 05/22/2003 | WO2003041649A2 Cyanoalkylamino derivatives as protease inhibitors |
| 05/22/2003 | WO2002076940A3 Process for preparing arylpiperidine carbinol intermediates and derivatives |
| 05/22/2003 | WO2002026705A8 Highly enantiomerically pure lactam-substituted propanoic acid derivatives and their preparation |
| 05/22/2003 | WO2000037429A3 INHIBITORS OF α4β1 MEDIATED CELL ADHESION |
| 05/22/2003 | US20030097004 3,4-Di-substituted cyclobutene-1,2-diones as CXC chemokine receptor antagonists |
| 05/22/2003 | US20030096864 Compounds to treat alzheimer's disease |
| 05/22/2003 | US20030096858 The parent drug compound is modified by forming one or more of predetermined chemical arrangement within parent drug structure for programming specific course and rate of metabolism for drug that leads to inactive nontoxic metabolite |
| 05/22/2003 | US20030096847 For treatment and/or prevention of disorders in the central nervous system, particularly amnesia, dementia, Alzheimer's dementia |
| 05/22/2003 | US20030096833 Use in inhibiting inflammation, cell death and in treating shock and reperfusion injuries |
| 05/22/2003 | US20030096828 Cyclic amide compound |
| 05/22/2003 | US20030096827 Heterocyclic amine derivatives; for treating an inflammatory or immune disease, a cardiovascular disease, or a neurodegenerative condition |
| 05/22/2003 | US20030096806 For use as pesicides, herbicides; crop protection |
| 05/22/2003 | US20030096796 N-cyanomethyl amides which are cysteine protease inhibitors; use treating diseases associated with activity of cathepsins B, K, L or S such as autoimmune disorders, allergic disorder, allogeneic immune response, cardiovascular disorders |
| 05/22/2003 | US20030096737 Caspase inhibitors and uses thereof |
| 05/22/2003 | US20030095992 Altering a drug's distribution, metabolism and elimination properties, especially by modifying with aralkyl ester moieties to increase rate of metabolism to inactive and nontoxic metabolites when exposure is halted; surgery, riots |
| 05/22/2003 | US20030095958 Inhibiting beta amyloid converting enzyme responsible for A beta peptide cleavage to treat Alzheimer's Disease, Down's Syndrome, etc. |
| 05/22/2003 | CA2466465A1 Nk1 antagonists |
| 05/22/2003 | CA2466440A1 Cannabinoid receptor ligands |
| 05/22/2003 | CA2466115A1 Cyanoalkylamino derivatives as protease inhibitors |
| 05/22/2003 | CA2464863A1 N-adamantylmethyl derivates and intermediates as pharmaceutical compositions and processes for their preparation |
| 05/22/2003 | CA2464861A1 Piperidine derivatives and their use as modulators of chemokine receptor activity (especially ccr5) |
| 05/22/2003 | CA2464347A1 Piperidine derivatives and their use as modulators of chemokine receptor activity (especially ccr5) |
| 05/21/2003 | EP1312923A2 Method and kit for detecting, or determining the quantity of, metabolites of fentanyl and metabolites of fentanyl analogs |
| 05/21/2003 | EP1312600A1 Process for separating mixtures of crude, water-containing amines originating from the amine synthesis |
| 05/21/2003 | EP1312599A1 Process for separating mixtures of crude, water-containing amines originating from the amine synthesis |
| 05/21/2003 | EP1311499A2 Bicyclic compounds as h3 receptor ligands |
| 05/21/2003 | EP1311482A2 Non-imidazole aryloxypiperidines as h3 receptor ligands |
| 05/21/2003 | EP1311476A1 Aza-amino acid derivatives (factor x a?-inhibitors 15) |
| 05/21/2003 | EP1311475A1 Novel aminocyclohexane derivatives |
| 05/21/2003 | EP1311473A2 Novel compounds inhibiting factor xa activity |
| 05/21/2003 | EP1311272A1 Novel methods using cholinesterase inhibitors |
| 05/21/2003 | EP1071656B1 Fluorovinyloxyacetamides, process for preparing same and herbicidal composition comprising same |
| 05/21/2003 | EP0874818B1 Novel substituted aryl compounds useful as modulators of acetylcholine receptors |
| 05/21/2003 | CN1418882A Substituted sulfonic N-[(amino imino methyl) phenyl alkyl]-acacycloamide compound |
| 05/21/2003 | CN1109032C Compounds analogous to thalidomide from class comprising pipeidine-2,6-diones |
| 05/21/2003 | CN1108814C Process for manufacture of pharmaceutical composition containing polyethylene glycol protein conjugates |
| 05/20/2003 | US6566526 Intermediates useful for the preparation of antihistaminic piperidine derivatives |
| 05/20/2003 | US6566525 Preparation of N-substituted-hydroxycycloalkylamine derivatives |
| 05/20/2003 | US6566509 Compound for use as bactericide |
| 05/20/2003 | US6566468 Provide polymeric resin products having low polydispersity; polymers produced contain a glycidyl or alkylcarbonyl group attached to the starting molecule of the radical chain reaction. |
| 05/20/2003 | US6566364 Linear or cyclic ureas |
| 05/20/2003 | US6566359 For use as platelet- activating factor antagonists, inhibitors of certain protein kinases, transcriptional inhibitors of COX-2(cyclooxygenase-2) expression, and as agents in protecting brain tissue from injuries related to trauma |
| 05/20/2003 | US6565997 Superior in vibration transmittability between ceramic substrate and piezoelectric |
| 05/20/2003 | CA2144962C 1-(2-oxo-acetyl)-piperidine-2-carboxylic acid derivatives as multi-drug-resistant cancer cell sensitizers |
| 05/20/2003 | CA2091668C Process for producing n-substituted polyhydroxy nitrogen-containing heterocycles |
| 05/15/2003 | WO2003040099A1 Preparation of benzosuberonylpiperidine compounds |
| 05/15/2003 | WO2003040096A2 N, n'-substituted-1,3-diamino-2-hydroxypropane derivatives |
| 05/15/2003 | WO2003040086A1 5-amidino-2-hydroxybenzenesulfonamide derivatives, medicinal compositions containing the same, medicinal use thereof and intermediates in the production thereof |
| 05/15/2003 | WO2003039482A2 Polymorphs of fexofenadine base |
| 05/15/2003 | WO2003007071A3 Novel nonlinear optical compounds and polymers |
| 05/15/2003 | WO2002102983A3 Oligomers and polymers of di-substituted cyclic imino carboxylic acids |
| 05/15/2003 | WO2002053537A8 Process for preparing (±) trans-4-p-fluorophenyl-3-hydroxymethyl-1-methylpiperidine |
| 05/15/2003 | US20030092869 Crosslinking; heat resistance, stability |
| 05/15/2003 | US20030092764 Oxidation resistance |
| 05/15/2003 | US20030092733 Chemical intermediate for drugs |
| 05/15/2003 | US20030092732 Eating disorders; dietetics; antiinflammatory agents; autoimmune diseases |
| 05/15/2003 | US20030092731 Synthesis of (4-bromopnenyl)(4-piperidyl)methanone-(Z)-O-ethyloxime and salts |
| 05/15/2003 | US20030092715 Aryl and biaryl compounds having MCH modulatory activity |
| 05/15/2003 | US20030092708 Anticholesterol agents; cardiovascular disorders; antilipemic agents |
| 05/15/2003 | US20030092704 Novel arylglycinamide derivatives, method of producing said derivatives and pharmaceutical compositions containing these compounds |
| 05/15/2003 | US20030089592 Process for fractionating water-containing crude amine mixtures from amine synthesis |
| 05/15/2003 | US20030089591 For the preparation of dimethylpropylamine from dimethylamine and propionaldehyde in the presence of hydrogen |
| 05/15/2003 | CA2466284A1 N, n'-substituted-1,3-diamino-2-hydroxypropane derivatives |
| 05/15/2003 | CA2465913A1 Polymorphs of fexofenadine base |
| 05/15/2003 | CA2464763A1 5-amidino-2-hydroxybenzenesulfonamide derivatives, medicinal compositions containing the same, medicinal use thereof and intermediates in the production thereof |
| 05/14/2003 | EP1310797A2 Method of monitoring neuroprotective treatment |
| 05/14/2003 | EP1310488A1 Fused bicyclic amide compounds and medicinal use thereof |
| 05/14/2003 | EP1309557A1 Amlodipine hemimaleate |
| 05/14/2003 | EP1309555A1 Process for making amlodipine maleate |
| 05/14/2003 | EP1309554A1 Amide derivative of amlodipine |
| 05/14/2003 | EP1309549A1 Acetamide derivatives and the use thereof as inhibitors of coagulation factors xa and viia |
| 05/14/2003 | EP1309325A1 Anticonvulsant derivatives useful for the treatment of depression |
| 05/14/2003 | EP1102746B1 Substituted phenylamidines with antithrombotic action |
| 05/14/2003 | EP1045842B1 Methods of use and compositions for benzylidene- and cinnamylidene-anabaseines |
| 05/14/2003 | EP0934313B1 N-substituted azaheterocyclic compounds |
| 05/14/2003 | CN1418193A heterocyclic side chain containing metalloprotease inbibitors |
| 05/14/2003 | CN1418121A Compound with 5-HT1A activity useful for treating disorders of outer retina |
| 05/14/2003 | CN1418100A Compounds with 5-HT activity useful for controlling visual field loss |
| 05/14/2003 | CN1417209A Tetrahydroquinoline ketopiperidine compounds and their prepn and use |
| 05/14/2003 | CN1108301C Inhibitors of microsomal triglyceride transfer protein and mothed |
| 05/13/2003 | US6562978 N-(3-(4-(4-(Aminocarbonyl)benzyl)-1-piperidinyl)propyl)-N-(3, 4-dichlorophenyl)-1-(methylsulfonyl)-4-piperidinecarboxamide or a salt thereof for treatment of AIDS |
| 05/13/2003 | US6562977 For use in the synthesis of peptides and/or for the manufacture of pharmaceutically active substances or corresponding intermediates |
| 05/13/2003 | US6562825 For treating inflammatory disease including asthma and allergic diseases, as well as autoimmune pathologies |
| 05/13/2003 | US6562824 Dihydropyridine soft drugs, and related compositions and methods |
| 05/13/2003 | US6562335 NK-1 receptor antagonists for prevention of neurogenic inflammation in gene therapy |
| 05/13/2003 | CA2259655C 1,4-di-sustituted piperidines as muscarinic antagonists |
| 05/13/2003 | CA2115443C Azabicyclo arylacetylene and arylenyne oximes as cholinergic agents and methods of treatment |
| 05/08/2003 | WO2003037889A1 Compounds and method for the treatment of overactive bladder |
| 05/08/2003 | WO2003037865A1 Novel anticancer compounds |
| 05/08/2003 | WO2003037853A1 Substituted thioacetamides |
| 05/08/2003 | WO2003037338A2 Modulators of the cholesterol biosynthetic pathway |
| 05/08/2003 | WO2003037328A1 Oxindole hydrazide modulators of protein tyrosine phosphatases (ptps) |
| 05/08/2003 | WO2003037271A2 Compounds, pharmaceutical compositions and methods of use therefor |
| 05/08/2003 | WO2002026750A8 Phosphino-aminophosphines, catalyst complexes and enantioselective hydrogenation |
| 05/08/2003 | US20030087956 Useful in the treatment of disease mediated by the interaction between VCAM-1 and/or fibronectin and the integrin receptor alpha 4 beta 1. |